Clinical Research Directory

Inclusion Criteria: * Volunteers aged between 40 and 80 years, who are communicative and cooperative, * Diagnosed with COPD for at least 3 months, * Receiving dual or triple regular pharmacological therapy for at least 3 months, * Post-bronchodilator FEV1/FVC \<70% and predicted FEV1 \<80% on spirometry, mMRC (Modified Medical Research Council) dyspnea score of 2 or higher, * COPD Assessment Test (CAT) score of 10 or higher. Exclusion Criteria: * Patients who do not consent to participate in the study, * Patients with communication difficulties or with visual, walking, or hearing impairments, * Patients currently experiencing a COPD exacerbation or with a history of exacerbation within the past month, * Patients with Stage 1 COPD (FEV1 ≥ 80%), * COPD patients receiving monotherapy, * Patients with mMRC score \<2 and CAT score \<10, * Patients with unstable angina, acute myocardial infarction (within 3-5 days), uncontrolled arrhythmia, active endocarditis, acute myocarditis/pericarditis, symptomatic severe aortic stenosis, lower extremity DVT, uncontrolled asthma/COPD, pulmonary edema, oxygen saturation (SpO₂) ≤ 90%, acute respiratory failure, or suspected dissecting aneurysm, * Patients receiving long-term oxygen therapy (LTOT), * COPD patients who have experienced more than two exacerbations in the past year. Withdrawal Criteria: * Patients who are unable to complete acupuncture sessions or follow-up assessments in the control group for any reason, * Patients who experience an exacerbation during the study (they will be reassessed one month after recovery and may be re-included if eligible), * Patients who miss more than two acupuncture sessions.